Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV000166459 | SCV000217255 | uncertain significance | Hereditary cancer-predisposing syndrome | 2016-09-02 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: Insufficient or conflicting evidence |
| Counsyl | RCV000409704 | SCV000488198 | uncertain significance | Familial adenomatous polyposis 1 | 2016-01-27 | criteria provided, single submitter | clinical testing | |
| Invitae | RCV000409704 | SCV000823577 | uncertain significance | Familial adenomatous polyposis 1 | 2018-06-20 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with proline at codon 2466 of the APC protein (p.Ser2466Pro). The serine residue is highly conserved and there is a moderate physicochemical difference between serine and proline. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with APC-related disease. ClinVar contains an entry for this variant (Variation ID: 186808). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |